Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  137,108 results for ""Cytarabine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma.

  • Authors : Yi JH; Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.; Kim SJ

Subjects: Rituximab*/Rituximab*/Rituximab*/administration & dosage ; Rituximab*/Rituximab*/Rituximab*/adverse effects ; Rituximab*/Rituximab*/Rituximab*/therapeutic use

  • Source: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1773-1781. Date of Electronic Publication: 2024 Aug 05.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

  • Authors : Rubino V; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland

Subjects: Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/therapy

  • Source: Cell reports. Medicine [Cell Rep Med] 2024 Nov 19; Vol. 5 (11), pp. 101826. Date of Electronic Publication: 2024 Nov 12.Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway.

  • Authors : Kong Q; Department of Pediatrics, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510000, P.R. China.; Liang Q

Subjects: Sirtuin 1*/Sirtuin 1*/Sirtuin 1*/metabolism ; Sirtuin 1*/Sirtuin 1*/Sirtuin 1*/genetics ; Cytarabine*/Cytarabine*/Cytarabine*/pharmacology

  • Source: International journal of oncology [Int J Oncol] 2025 Jan; Vol. 66 (1). Date of Electronic Publication: 2024 Nov 22.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.

  • Authors : Récher C; Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.; Dumas PY

Subjects: Cytarabine*/Cytarabine*/Cytarabine*/administration & dosage ; Cytarabine*/Cytarabine*/Cytarabine*/therapeutic use ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy

  • Source: American journal of hematology [Am J Hematol] 2025 Jan; Vol. 100 (1), pp. 23-32. Date of Electronic Publication: 2024 Nov 18.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Azacitidine and cytarabine induce sustained lymphopenia with abnormal differentiation of common lymphoid progenitors and prolonged suppression of Dnmt3a and Dnmt3b expression in mice.

  • Authors : Matsushita J; Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd, Tokyo 134-8630, Japan.; Miwa K

Subjects: Cytarabine*/Cytarabine*/Cytarabine*/toxicity ; Azacitidine*/Azacitidine*/Azacitidine*/toxicity ; DNA (Cytosine-5-)-Methyltransferases*/DNA (Cytosine-5-)-Methyltransferases*/DNA (Cytosine-5-)-Methyltransferases*/genetics

  • Source: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2025 Jan 01; Vol. 203 (1), pp. 96-104.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia.

  • Authors : Vervoort BMT; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS.; Butler M

Subjects: Ikaros Transcription Factor*/Ikaros Transcription Factor*/Ikaros Transcription Factor*/genetics ; Cytarabine*/Cytarabine*/Cytarabine*/pharmacology ; Cytarabine*/Cytarabine*/Cytarabine*/therapeutic use

  • Source: Haematologica [Haematologica] 2024 Dec 01; Vol. 109 (12), pp. 3904-3917. Date of Electronic Publication: 2024 Dec 01.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Drug-Drug Cocrystal Alloy and Nanoformulation of Cytarabine: Optimized Biopharmaceutical Property and Synergistic Antitumor Efficacy.

  • Authors : Yu YM; Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science, Qingdao, Shandong 266234, PR China.; School of Medicine, Linyi University, Linyi, Shandong 276000, PR China.

Subjects: Fluorouracil*/Fluorouracil*/Fluorouracil*/chemistry ; Fluorouracil*/Fluorouracil*/Fluorouracil*/pharmacology ; Fluorouracil*/Fluorouracil*/Fluorouracil*/administration & dosage

  • Source: Molecular pharmaceutics [Mol Pharm] 2024 Nov 04; Vol. 21 (11), pp. 5716-5727. Date of Electronic Publication: 2024 Oct 11.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Isocitrate dehydrogenase 2 mutation promotes cytarabine resistance in acute myeloid leukemia by Warburg effect.

  • Authors : Yang J; Department of Hematology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Hematology Research Center of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Subjects: Cytarabine*/Cytarabine*/Cytarabine*/pharmacology ; Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/metabolism

  • Source: Hematological oncology [Hematol Oncol] 2024 Nov; Vol. 42 (6), pp. e3316.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069

Record details

Read More Add to Saved list
×
Academic Journal

n-3 polyunsaturated fatty acids enhanced efficacy of cytarabine in iron-overloaded NALM-6 cells via apoptotic and oxidative pathways.

  • Authors : Bahraini F; Birjand University of Medical Sciences, Birjand, Iran. Electronic address: .; Sayadi M

Subjects: Cytarabine*/Cytarabine*/Cytarabine*/pharmacology ; Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/pharmacology

  • Source: Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2025 Mar; Vol. 103, pp. 105976. Date of Electronic Publication: 2024 Nov 28.Publisher: Pergamon Press Country of Publication: England NLM ID: 8712158 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Protective effect of alpha‑lipoic acid against in utero cytarabine exposure-induced hepatotoxicity in rat female neonates.

  • Authors : Namoju R; Department of Pharmacology, GITAM School of Pharmacy, GITAM Deemed to be University, Visakhapatnam, Andhra Pradesh, 530045, India. .; Department of Pharmacology, Bhaskar Pharmacy College, Jawaharlal Nehru Technical University, Hyderabad, Telangana, 500075, India. .

Subjects: Thioctic Acid*/Thioctic Acid*/Thioctic Acid*/pharmacology ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/prevention & control ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/pathology

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Sep; Vol. 397 (9), pp. 6577-6589. Date of Electronic Publication: 2024 Mar 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  137,108 results for ""Cytarabine""